EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

MLA

Pao, William, et al. “EGF Receptor Gene Mutations Are Common in Lung Cancers from ‘Never Smokers’ and Are Associated with Sensitivity of Tumors to Gefitinib and Erlotinib.” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 36, Sept. 2004, pp. 13306–11. EBSCOhost, https://doi.org/10.1073/pnas.0405220101.

APA

Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., Mardis, E., Kupfer, D., Wilson, R., Kris, M., & Varmus, H. (2004). EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proceedings of the National Academy of Sciences of the United States of America, 101(36), 13306–13311. https://doi.org/10.1073/pnas.0405220101

Chicago

Pao, William, Vincent Miller, Maureen Zakowski, Jennifer Doherty, Katerina Politi, Inderpal Sarkaria, Bhuvanesh Singh, et al. 2004. “EGF Receptor Gene Mutations Are Common in Lung Cancers from ‘Never Smokers’ and Are Associated with Sensitivity of Tumors to Gefitinib and Erlotinib.” Proceedings of the National Academy of Sciences of the United States of America 101 (36): 13306–11. doi:10.1073/pnas.0405220101.